Mitotech and Essex Bio-Technology announce positive results of VISTA-2...

Both VISTA-2 and VISTA-1 demonstrated significant impact of SkQ1 on clearing of Central Corneal Fluorescein Staining (CCFS) and improvement of Best Corrected Visual Acuity (BCVA) at day 28 (p<0.05...(PRWeb February 26, 2021)Read the full story at https://www.prweb.com/releases/mitotech_and_essex_bio_technology_announce_positive_results_of_vista_2_phase_3_clinical_study_in_dry_eye_disease/prweb17752486.htm

Source: PRWeb: Medical Pharmaceuticals - February 26, 2021 Category: Pharmaceuticals Source Type: news